These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1105 related items for PubMed ID: 26361355

  • 21. Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder?
    Olanow CW, Brundin P.
    Mov Disord; 2013 Jan; 28(1):31-40. PubMed ID: 23390095
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Identification of Drosophila MicroRNA targets.
    Stark A, Brennecke J, Russell RB, Cohen SM.
    PLoS Biol; 2003 Dec; 1(3):E60. PubMed ID: 14691535
    [Abstract] [Full Text] [Related]

  • 24. MALAT1 Mediates α-Synuclein Expression through miR-23b-3p to Induce Autophagic Impairment and the Inflammatory Response in Microglia to Promote Apoptosis in Dopaminergic Neuronal Cells.
    Geng X, Zou Y, Li S, Qi R, Yu H, Li J.
    Mediators Inflamm; 2023 Dec; 2023():4477492. PubMed ID: 37064502
    [Abstract] [Full Text] [Related]

  • 25. Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease.
    Gui Y, Liu H, Zhang L, Lv W, Hu X.
    Oncotarget; 2015 Nov 10; 6(35):37043-53. PubMed ID: 26497684
    [Abstract] [Full Text] [Related]

  • 26. Wild-type and mutant alpha-synuclein induce a multi-component gene expression profile consistent with shared pathophysiology in different transgenic mouse models of PD.
    Miller RM, Kiser GL, Kaysser-Kranich T, Casaceli C, Colla E, Lee MK, Palaniappan C, Federoff HJ.
    Exp Neurol; 2007 Mar 10; 204(1):421-32. PubMed ID: 17254569
    [Abstract] [Full Text] [Related]

  • 27. Expression signatures of long non-coding RNA in the substantia nigra of pre-symptomatic mouse model of Parkinson's disease.
    Jiao F, Wang Q, Zhang P, Bu L, Yan J, Tian B.
    Behav Brain Res; 2017 Jul 28; 331():123-130. PubMed ID: 28476570
    [Abstract] [Full Text] [Related]

  • 28. LncRNA miR-17-92a-1 cluster host gene (MIR17HG) promotes neuronal damage and microglial activation by targeting the microRNA-153-3p/alpha-synuclein axis in Parkinson's disease.
    Zhang J, Yang Y, Zhou C, Zhu R, Xiao X, Zhou B, Wan D.
    Bioengineered; 2022 Feb 28; 13(2):4493-4516. PubMed ID: 35137671
    [Abstract] [Full Text] [Related]

  • 29. Alteration in alpha-synuclein mRNA expression in Parkinson's disease.
    Kingsbury AE, Daniel SE, Sangha H, Eisen S, Lees AJ, Foster OJ.
    Mov Disord; 2004 Feb 28; 19(2):162-70. PubMed ID: 14978671
    [Abstract] [Full Text] [Related]

  • 30. Generation of a alpha-synuclein-based rat model of Parkinson's disease.
    Recchia A, Rota D, Debetto P, Peroni D, Guidolin D, Negro A, Skaper SD, Giusti P.
    Neurobiol Dis; 2008 Apr 28; 30(1):8-18. PubMed ID: 18313315
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. A Drosophila model of Parkinson's disease.
    Feany MB, Bender WW.
    Nature; 2000 Mar 23; 404(6776):394-8. PubMed ID: 10746727
    [Abstract] [Full Text] [Related]

  • 33. Differential interaction between iron and mutant alpha-synuclein causes distinctive Parkinsonian phenotypes in Drosophila.
    Zhu ZJ, Wu KC, Yung WH, Qian ZM, Ke Y.
    Biochim Biophys Acta; 2016 Apr 23; 1862(4):518-525. PubMed ID: 26769358
    [Abstract] [Full Text] [Related]

  • 34. Parkinson's disease risk genes act in glia to control neuronal α-synuclein toxicity.
    Olsen AL, Feany MB.
    Neurobiol Dis; 2021 Nov 23; 159():105482. PubMed ID: 34390834
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Differential expression of miR-34a, miR-141, and miR-9 in MPP+-treated differentiated PC12 cells as a model of Parkinson's disease.
    Rostamian Delavar M, Baghi M, Safaeinejad Z, Kiani-Esfahani A, Ghaedi K, Nasr-Esfahani MH.
    Gene; 2018 Jul 01; 662():54-65. PubMed ID: 29631008
    [Abstract] [Full Text] [Related]

  • 37. Identification and profiling of Cyprinus carpio microRNAs during ovary differentiation by deep sequencing.
    Wang F, Jia Y, Wang P, Yang Q, Du Q, Chang Z.
    BMC Genomics; 2017 Apr 28; 18(1):333. PubMed ID: 28454515
    [Abstract] [Full Text] [Related]

  • 38. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
    Tong J, Wong H, Guttman M, Ang LC, Forno LS, Shimadzu M, Rajput AH, Muenter MD, Kish SJ, Hornykiewicz O, Furukawa Y.
    Brain; 2010 Jan 28; 133(Pt 1):172-88. PubMed ID: 19903734
    [Abstract] [Full Text] [Related]

  • 39. Identification of miRNA-7 as a regulator of brain-derived neurotrophic factor/α-synuclein axis in atrazine-induced Parkinson's disease by peripheral blood and brain microRNA profiling.
    Li B, Jiang Y, Xu Y, Li Y, Li B.
    Chemosphere; 2019 Oct 28; 233():542-548. PubMed ID: 31185338
    [Abstract] [Full Text] [Related]

  • 40. Distinct pattern of enteric phospho-alpha-synuclein aggregates and gene expression profiles in patients with Parkinson's disease.
    Barrenschee M, Zorenkov D, Böttner M, Lange C, Cossais F, Scharf AB, Deuschl G, Schneider SA, Ellrichmann M, Fritscher-Ravens A, Wedel T.
    Acta Neuropathol Commun; 2017 Jan 05; 5(1):1. PubMed ID: 28057070
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 56.